本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Day One Biopharmaceuticals Inc.

6.79
-0.4000-5.56%
盤後6.790.00000.00%17:47 EDT
成交量:114.89萬
成交額:796.16萬
市值:6.88億
市盈率:-9.56
高:7.13
開:7.10
低:6.78
收:7.19
資料載入中...
2025/06/03

重要事件披露

Form 8-K - Current report
2025/05/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/06

重要事件披露

Form 8-K - Current report
2025/03/06

[修訂]年度報告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2025/02/26

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/26

重要事件披露

Form 8-K - Current report
2025/02/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/13

重要事件披露

Form 8-K - Current report
2025/01/10

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/11/20

重要事件披露

Form 8-K - Current report
2024/11/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/15

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities